Is there a Benefit from the Concomitant Use of Immunosupression with Anti-TNF in Crohn's Disease; Heads or Tails?

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|4|3|152-158

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.4, Iss.3, 2009-09, pp. : 152-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

To (anti‐)TNF or not (anti‐)TNF? That is the question in pemphigus

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 3, 2015-03 ,pp. : 564-565

John Wiley & Sons Inc

Access to resources Recommend Favorite

Severe deafness associated with Crohns disease and spondylarthropathy: successful treatment with anti-TNF

By Jachiet Marie  

British Journal of Rheumatology , Vol. 52, Iss. 6, 2013-06 ,pp. : 1145-1147

Oxford University Press

Access to resources Recommend Favorite

Efficacy and safety of anti‐TNF therapy in elderly patients with inflammatory bowel disease

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 4, 2015-08 ,pp. : 441-451

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systematic review with meta‐analysis: the efficacy of a second anti‐TNF in patients with inflammatory bowel disease whose previous anti‐TNF treatment has failed

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 7, 2015-04 ,pp. : 613-623

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 8, 2015-10 ,pp. : 977-989

John Wiley & Sons Inc

Access to resources Recommend Favorite